0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

FATALITY RATES IN THE TREATMENT OF 998 ERYSIPELAS PATIENTS:  THE INFLUENCE OF SULFANILAMIDE

ARCHIBALD L. HOYNE, M.D.; A. ALVIN WOLF, M.D.; LEONA PRIM, R.N.
JAMA. 1939;113(26):2279-2281. doi:10.1001/jama.1939.02800510001001.
Text Size: A A A
Published online

Hippocrates gave a fair description of erysipelas and Galen more closely defined it. Since then various forms of treatment have been as numerous as the centuries that have elapsed. That this disease cannot be ignored as a cause of death is shown in table 1. It may be noted that for the first year of the quinquennium, with 196 patients, the fatality rate was 17.3 per cent, whereas in 1938 among 141 patients the death rate was only 2.1 per cent. Even the last named figure, which includes those of all ages, is of sufficient significance to view with alarm patients in the two extremes of life when the death rates are highest. Surgical patients and those suffering from chronic diseases or conditions in which malnutrition is an important factor are also serious, because in such groups fatality rates are often very high. It is for these reasons that we

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();